+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

U.S. Pharmaceutical Analytical Testing Outsourcing Market Size, Share & Trends Analysis Report by Service (Bioanalytical Testing, Method Development & Validation), by End-use, and Segment Forecasts, 2020-2027

  • ID: 5230443
  • Report
  • November 2020
  • Region: United States
  • 84 Pages
  • Grand View Research

FEATURED COMPANIES

  • Boston Analytical
  • Eurofins Scientific
  • Intertek Group Plc
  • Sgs Sa
  • Wuxi Apptec, Inc.
U.S. Pharmaceutical Analytical Testing Outsourcing Market Growth & Trends

The U.S. pharmaceutical analytical testing outsourcing market size is expected to reach USD 5.55 billion by 2027. It is expected to expand at a CAGR of 8.3% from 2020 to 2027. The market is mainly driven by an increasing number of clinical trial registrations, innovations in the medical industry, and the entry of new players in the market. Moreover, increasing R&D investment, growing demand for biopharmaceutical products, and rising focus on regulation, safety, and quality are some of the major factors responsible for the growth of the market. The pharmaceutical analytical testing involves outsourcing of various types of evaluation such as
  • Analytical Method Development Services.
  • Analytical Method Validation Services.
  • Bioanalytical Services / Bioanalytical Testing Services (Bioanalytical CRO).
  • Pharmaceutical Biomarker Testing Services / Biomarker Services.
  • Preclinical Toxicology Testing Services (in vitro).
  • Pharmaceutical Contract Bioavailability Testing Services.
  • Others.

The increasing development of the pharmaceutical analytical testing services market has fascinated many new players in the industry, leading to growing competition for well established, standalone service providers. The rapid increase in the manufacturing of medications to meet the rising demand for efficient healthcare in the U.S. is projected to be one of the major factors driving the demand for pharmaceutical analytical testing outsourcing services. For example, the increasing prevalence of preventable illness and the suboptimal use of healthcare resources have led to rising demand for efficient healthcare in the U.S.

The bioanalytical testing service segment is anticipated to witness the fastest growth over the forecast period. Additionally, ancillary services such as storage, registration and testing, process and cleaning validations, and facility validation are widely being outsourced, which, in turn, is expected to help boost the market growth. Therefore, the outsourcing of analytical testing services provides quality results and is also a cost-effective solution.

U.S. Pharmaceutical Analytical Testing Outsourcing Market Report Highlights
  • By service, the bioanalytical testing segment held the second-largest share in 2019 due to increasing preference for outsourcing analytical testing.
  • By end-use, pharmaceutical companies accounted for the largest share of 47.6% in 2019 owing to innovative approaches to moderate the complexity of tests.
  • Growing demand for biopharmaceuticals, analytical drugs, and biosimilars is anticipated to be one of the key factors enhancing the market growth.
  • An increasing number of clinical trial registrations and entry of new participants in the market over the past decade are the key factors likely to propel the biopharmaceutical companies end-use segment over the forecast period.


This product will be delivered within 1-3 business days.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Boston Analytical
  • Eurofins Scientific
  • Intertek Group Plc
  • Sgs Sa
  • Wuxi Apptec, Inc.


Chapter 1 Methodology and Scope
1.1 Market Segmentation & Scope
1.1.1 Service
1.1.2 End Use
1.1.3 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Internal database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective - 1
1.10.2 Objective - 2
1.10.3 Objective - 3
1.10.4 Objective - 4
Chapter 2 Executive Summary
2.1 Market Outlook
Chapter 3 U.S. Pharmaceutical Analytical Testing Outsourcing Market: Variables, Trends, & Scope
3.1 Segment Outlook
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.1.1 Increasing innovation in testing services
3.2.1.2 Regulation safety and quality
3.2.1.3 Pricing
3.2.2 Market Restraint Analysis
3.2.2.1 Data insecurity
3.2.2.2 Third-party performance
3.3 Penetration & Growth Prospect Mapping
3.4 U.S. Pharmaceutical Analytical Testing Outsourcing: Market Analysis Tools
3.4.1 Porter’s Five Forces Analysis
3.4.2 PESTEL Analysis
Chapter 4 U.S. Pharmaceutical Analytical Testing Outsourcing Market: Service Segment Analysis
4.1 U.S. Pharmaceutical Analytical Testing Outsourcing: Market Share Analysis, 2019 & 2027
4.2 Bioanalytical Testing
4.2.1 Bioanalytical Testing Market, 2016 - 2027 (USD Million)
4.2.2 Clinical
4.2.2.1 Clinical market, 2016 - 2027 (USD Million)
4.2.3 Non-clinical
4.2.3.1 Non-clinical market, 2016 - 2027 (USD Million)
4.3 Method Development & Validation
4.3.1 Method Development & Validation Market, 2016 - 2027 (USD Million)
4.3.2 ExtracTable & Leachable
4.3.2.1 ExtracTable & Leachable market, 2016 - 2027 (USD Million)
4.3.3 Impurity Method
4.3.3.1 Impurity Method market, 2016 - 2027 (USD Million)
4.3.4 Technical Consulting
4.3.4.1 Technical Consulting market, 2016 - 2027 (USD Million)
4.3.5 Others
4.3.5.1 Others market, 2016 - 2027 (USD Million)
4.4 Stability Testing
4.4.1 Stability Testing Market, 2016 - 2027 (USD Million)
4.4.2 Drug Substance
4.4.2.1 Drug Substance market, 2016 - 2027 (USD Million)
4.4.3 Stability Indicating Method Validation
4.4.3.1 Stability Indicating Method Validation market, 2016 - 2027 (USD Million)
4.4.4 Accelerated Stability Testing
4.4.4.1 Accelerated Stability Testing market, 2016 - 2027 (USD Million)
4.4.5 Photostability Testing
4.4.5.1 Photostability Testing market, 2016 - 2027 (USD Million)
4.4.6 Others
4.4.6.1 Others market, 2016 - 2027 (USD Million)
4.5 Other Testing Services
Chapter 5 U.S. Pharmaceutical Analytical Testing Outsourcing Market: End-use Segment Analysis
5.1 U.S. Pharmaceutical Analytical Testing Outsourcing: Market Share Analysis, 2019 & 2027
5.2 Pharmaceutical Companies
5.2.1 Pharmaceutical Companies U.S. Pharmaceutical Analytical Testing Outsourcing Market, 2016 - 2027 (USD Million)
5.3 Biopharmaceutical Companies
5.3.1 Biopharmaceutical Companies U.S. Pharmaceutical Analytical Testing Outsourcing Market, 2016 - 2027 (USD Million)
5.4 Contract Research Organizations
5.4.1 Contract Research Organisations U.S. Pharmaceutical Analytical Testing Outsourcing Market, 2016 - 2027 (USD Million)
Chapter 6 Competitive Analysis
6.1 Competitive Insights
6.2 Major Deals & Strategic Alliances Analysis
6.2.1 Mergers & Acquisitions
6.2.2 Expansions
6.2.3 Collaborations
6.2.4 Product Launch
Chapter 7 Company Profiles
7.1 Company Profiles
7.2 West Pharmaceutical Services, Inc.
7.2.1 Company Overview
7.2.2 Financial Performance
7.2.3 Service Benchmarking
7.2.4 Strategic Initiatives
7.3 Sgs Sa
7.3.1 Company Overview
7.3.2 Financial Performance
7.3.3 Service Benchmarking
7.3.4 Strategic Initiatives
7.4 Eurofins Scientific
7.4.1 Company Overview
7.4.2 Financial Performance
7.4.3 Service Benchmarking
7.4.4 Strategic Initiatives
7.5 Pace Analytical Services Llc
7.5.1 Company Overview
7.5.2 Service Benchmarking
7.5.3 Strategic Initiatives
7.6 Intertek Group Plc
7.6.1 Company Overview
7.6.2 Financial Performance
7.6.3 Service Benchmarking
7.6.4 Strategic Initiatives
7.7 Pharmaceutical Product Development, LLC.
7.7.1 Company Overview
7.7.2 Financial Performance
7.7.3 Service Benchmarking
7.7.4 Strategic Initiatives
7.8 Wuxi Apptec, Inc.
7.8.1 Company Overview
7.8.2 Financial Performance
7.8.3 Service Benchmarking
7.8.4 Strategic Initiatives
7.9 Boston Analytical
7.9.1 Company Overview
7.9.2 Service Benchmarking
7.9.3 Strategic Initiatives
7.10 Charles River Laboratories International, Inc.
7.10.1 Company Overview
7.10.2 Financial Performance
7.10.3 Service Benchmarking
7.10.4 Strategic Initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 U.S. Pharmaceutical Analytical Testing Outsourcing Market, By Service, 2016-2027 (USD Million)
Table 4 U.S. Pharmaceutical Analytical Testing Outsourcing Market, By End Use, 2016-2027 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Commodity Flow Analysis
Fig. 9 U.S. pharmaceutical analytical testing outsourcing market snapshot (2019)
Fig. 10 U.S. pharmaceutical analytical testing outsourcing: Market segmentation
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 Penetration & growth prospect mapping
Fig. 14 Porter’s five forces analysis
Fig. 15 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 16 U.S. Pharmaceutical Analytical Testing Outsourcing market service outlook: Segment dashboard
Fig. 17 U.S. pharmaceutical analytical testing outsourcing market: Service movement analysis
Fig. 18 Bioanalytical testing market, 2016 - 2027 (USD Million)
Fig. 19 Clinical market, 2016 - 2027 (USD Million)
Fig. 20 Non-clinical market, 2016 - 2027 (USD Million)
Fig. 21 Method development & validation market, 2016 - 2027 (USD Million)
Fig. 22 ExtracTable & leachable market, 2016 - 2027 (USD Million)
Fig. 23 Impurity method market, 2016 - 2027 (USD Million)
Fig. 24 Technical consulting market, 2016 - 2027 (USD Million)
Fig. 25 Others market, 2016 - 2027 (USD Million)
Fig. 26 Stability testing market, 2016 - 2027 (USD Million)
Fig. 27 Drug substance market, 2016 - 2027 (USD Million)
Fig. 28 Stability indicating method validation market, 2016 - 2027 (USD Million)
Fig. 29 Accelerated stability testing market, 2016 - 2027 (USD Million)
Fig. 30 Photostability testing market, 2016 - 2027 (USD Million)
Fig. 31 Other testing services market, 2016 - 2027 (USD Million)
Fig. 32 U.S. pharmaceutical analytical testing outsourcing market end-use outlook: Segment dashboard
Fig. 33 U.S. pharmaceutical analytical testing outsourcing market: End-use movement analysis
Fig. 34 Pharmaceutical companies market, 2016 - 2027 (USD Million)
Fig. 35 Biopharmaceutical companies market, 2016 - 2027 (USD Million)
Fig. 36 Contract research organizations market, 2016 - 2027 (USD Million)
Note: Product cover images may vary from those shown
  • West Pharmaceutical Services, Inc.
  • Sgs Sa
  • Eurofins Scientific
  • Pace Analytical Services Llc
  • Intertek Group Plc
  • Pharmaceutical Product Development, LLC.
  • Wuxi Apptec, Inc.
  • Boston Analytical
  • Charles River Laboratories International, Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...